TABLE 5.
Antimicrobial agent | Organism, strain (β-lactamase content) |
|||||||
---|---|---|---|---|---|---|---|---|
E. coli ESBL4 (CTX-M-15) |
E. cloacae ECL01 (TEM-72, ACT-1, P99AmpC) |
K. pneumoniae ATCC BAA-1705 (KPC-2) |
K. pneumoniae 752286 (OXA-48) |
|||||
MIC (μg/ml) | MBC (μg/ml) | MIC (μg/ml) | MBC (μg/ml) | MIC (μg/ml) | MBC (μg/ml) | MIC (μg/ml) | MBC (μg/ml) | |
CTB | 32 | >32 | 64 | >32 | 16 | 16 | 128 | ≥128 |
CTB-CLA | 0.12 | 1 | ≥256 | ≥256 | 8 | 16 | 16 | 16 |
CTB/VNRX-5236 | 0.12 | 0.12 | 0.25 | 1 | 0.12 | 0.25 | 0.25 | 0.25 |
AMC | 16 | 16 | 128 | ≥128 | ≥256 | ≥256 | ≥256 | ≥256 |
Sulopenem | 0.12 | 0.12 | 1 | 1 | 32 | 32 | 16 | >32 |
Tebipenem | ≤0.06 | 0.06 | 0.25 | 0.25 | 32 | 32 | 16 | >32 |
Levofloxacin | 32 | 32 | 0.12 | 0.12 | 64 | ≥64 | 32 | >32 |
MICs represent modal broth microdilution values from 5 independent determinations. MBCs are the lowest concentrations of compound tested in the time-kill experiment at 24 h that resulted in a ≥3-log10 CFU/ml reduction in bacterial counts from input. Shaded boxes represent data for the compound/pathogen combination shown in Fig. 3.